Table 2.
Sleep quality and its component scores among study subjects at JUMC, Ethiopia, 2018
| Study participants (N = 198) | |||
|---|---|---|---|
| Variables | Category | T2DM group N (%) | Non-diabetic group N (%) |
| Sleep duration | > 7 h | 21 (21.2) | 35 (35.4) |
| 6–7 h | 53 (53.5) | 45 (45.5) | |
| 5–6 h | 14 (14.1) | 17 (17.2) | |
| < 5 h | 11 (11.1) | 2 (2) | |
| Sleep latency | Never (0) | 25 (25.3) | 38 (38.4) |
| < 1 times a week (1) | 50 (50.5) | 44 (44.4) | |
| 1–2 times a week (2) | 20 (20.2) | 14 (14.1) | |
| ≥ 3 times a week (3) | 4 (4) | 3 (3) | |
| Sleep efficiency | ≥ 85% | 22 (22.2) | 57 (57.6) |
| 75–84% | 40 (40.4) | 28 (28.3) | |
| 65–74% | 11 (11.1) | 8 (8.1) | |
| < 65% | 26 (26.3) | 6 (6.1) | |
| Day time dysfunction | Never (0) | 38 (38.4) | 72 (72.7) |
| < 1 times a week (1) | 52 (52.5) | 26 (26.3) | |
| 1–2 times a week (2) | 8 (8.1) | 1 (1) | |
| ≥ 3 times a week (3) | 1 (1) | 0 | |
| Sleep disturbance | Never (0) | 3 (3) | 23 (23.2) |
| < 1 times a week (1) | 89 (89.9) | 76 (76.8) | |
| 1–2 times a week (2) | 6 (6.1) | 0 | |
| ≥ 3 times a week (3) | 1 (1) | 0 | |
| Use of sleep medication | Never (0) | 86 (86.9) | 95 (96) |
| < 1 times a week (1) | 12 (12.1) | 4 (4) | |
| 1–2 times a week (2) | 1 (1) | 0 | |
| Subjective sleep quality | Very good (0) | 25 (25.25) | 59 (59.6) |
| Fairly good (1) | 37 (37.4) | 36 (36.4) | |
| Fairly bad (2) | 21 (21.2) | 4 (4) | |
| Very bad (3) | 16 (16.15) | 0 | |